Alpha Tau Medical Ltd. Ordinary Shares (DRTS) Stock Price
DRTSStock
$14.64+335.71%52W
Market Cap$1.35B
P/E—
PEG Ratio—
Div yield—
Beta1.23
DRTS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)86.04%
Price vs S&P 500 (4W)21.28%
VGM Score89.51
DRTS Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.14 | -$0.50 | -254.91%(-$0.36) | |
| Q1 2026 | -$0.12 | -$0.26 | -110.42%(-$0.14) | |
| Q4 2025 | -$0.12 | -$0.14 | -13.35%(-$0.02) | |
| Q3 2025 | -$0.12 | -$0.14 | -21.37%(-$0.02) | |
| Q2 2025 | -$0.11 | -$0.13 | -13.75%(-$0.02) |
DRTS Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.20
4.18
4.18
4.18
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DRTSAlpha Tau Medical Ltd. Ordinary Shares | — | — | A | $14.64 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About Alpha Tau Medical Ltd. Ordinary Shares
Alpha Tau Medical is a clinical-stage oncology company developing Alpha DaRT, a proprietary technology that harnesses alpha particles for localized radiation therapy to treat solid tumors. The technology leverages alpha particles' therapeutic properties while addressing their traditionally limited range. The company is advancing its clinical pipeline with operations based in Israel.